The Nashville-based REIT closed the deal with Goddard InvestmentGroup LLC of Atlanta in recent days, allowing the one-year owner tocross off another piece of Dallas real estate on its "to go" list.The Pyramids, positioned on 6.6 acres at 9101 and 9201 N. CentralExpwy., came to market in May with two other class A officeproperties, with more than one million sf, in an opportunistic moveto take advantage of value-add capital looking for landing spots,according to aprevious interview with the seller.

Healthcare Realty didn't return telephone calls to comment onthe deal, which surfaced two days ago in an SEC filing. The sellerindicated it was unable to comment and its sales team confinedcomments to a press release that was issued late last night. TheHolliday Fenoglio Fowler LP team consisted of senior managingdirector Andrew S. Levy, director Todd W. Savage, director JohnBourret and analyst Kelsey Roop.

Seller financing at a fixed-rate interest and 70% LTV cap was anoption of the offering, but it couldn't be determined by deadlineif the REIT leveraged the 98%-leased Pyramids' purchase in any way.The lease stack has Baylor in 95,000 sf until June 2020 of the145,963-sf south tower and the Dallas Plastic Surgery Institute in33,664 sf through June 2023, with the multi-tenant balance mostlyfilled by medical tenants. The Pyramids' 145,426-sf north tower isfully occupied by XO Communications Inc., with a lease that expiresin July 2010.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.